Withpharmacological agonists and genetic manipulations of PPARδcoming to fruition in recent years, these expectations arestarting to be realized, and implicate PPARδ in importantaspects of obesity, energy metabolism and metabolic disease. This evidence concerns the gene PPARD and Obesity.